NXTpsychedelics (@NXTpsychedelics) header
NXTpsychedelics (@NXTpsychedelics) profile picture

NXTpsychedelics provides opinion and commentary, equity research and newsletters focused on the psychedelics sector and on what matters in today's economy.

Toronto
Joined April 2021
Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)Photo by NXTpsychedelics (@NXTpsychedelics)
Cantheon Provides Funding to Albert Labs for Psilocybin Drug Development Canadian biopharmaceutical company Albert Labs International Corp. secured a C$830,000 ($621,600) #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/li3ZlUZ2uc
51
The Science of Psychedelics & Spiritual Medicine Conference Are you ready to explore the fascinating world of psychedelics and spiritual medicine? #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/fFVmWWcSxV
45
Washington House Panel Amends Psilocybin Research Bill To Add Patient Access Provisions Back In A House committee in Washington State has amended and approved a psilocybin bill—inserting some therapeutic access provisions back into the legislation https://teapawt.net/t.co/jnUczyYRVm
10
Missouri House Advances Therapeutic Psilocybin Legalization And Research Bill The Missouri House is one step closer to passing a bill that would legalize psilocybin therapy for certain patients while promoting research into the #psychedelics https://teapawt.net/t.co/RpVy0F9LJL
32
Joël Brierre Calls To Those Seeking Transformation – Podcast Episode #24 On the season three premiere of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Joël Brierre. #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/FGet2MLLmW
28
IntelGenx Reports Fourth Quarter and Full-Year 2022 Financial Results #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/AncdN1ykAo
21
Psilocybin Therapies Attract Support in Illinois Legislature A coalition behind Illinois’ proposed CURE Act is proposing the statewide legalization of psilocybin and psilocybin therapy sparked by collaboration between a #psychedelics #PsychTwitter https://teapawt.net/t.co/LRQRPulEVB
55
Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs A Republican lawmaker in Massachusetts introduced a bill that would both reschedule the psychedelic MDMA at the state level and cap possible therapy costs at #psychedelics https://teapawt.net/t.co/9j3UsmU3rt
22
PharmaTher Announces Positive FDA Meeting; Path Towards Phase 3 Trial The article PharmaTher Announces Positive FDA Meeting; Path Towards Phase 3 Trial was originally published on Microdose. #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/rZWZPTHs2g
27
PSYC’s CEO to Moderate Panel at Film Screening for ESPN’s Upcoming Documentary, “Peace of Mind” PSYC Corporation (OTC Pink Market: PSYC), parent company to Spotlight Media Corporation (“SMC” #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/T2pMGxIjjy
21
Atai CEO Answers Questions From the Public The article Atai CEO Answers Questions From the Public was originally published on Microdose. Reddit is the internet incarnate. #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/EV5EklibOm
20
PSYC’s CEO to Moderate Panel at Film Screening for ESPN’s Upcoming Documentary, "Peace of Mind" LAS VEGAS, NV, March 29, 2023 (GLOBE NEWSWIRE) -- PSYC Corporation (OTC Pink Market: PSYC) (“PSYC”, #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/z3IxQYciCQ
32
BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) ( https://teapawt.net/t.co/zNclGUp57m
31
PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/Zm9mRkP4Sm
21
DE cannabis bills head to gov’s desk (Newsletter: March 29, 2023) KY gov pushes lawmakers on medical marijuana; Congressman slams fed laws; SC medical bill in danger; Colombian legalization vote; Military drug #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/Ox1nzGfzBb
21
Shifting Strategy, MAPS Turns to Equity Investment The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has for the first time offered to sell shares in its for-profit, drug-development #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/4sglAj8pHy
17
South Carolina Medical Marijuana Legalization Bill’s Fate In Question, But Supporters Are Making A Last-Ditch Push South Carolina lawmakers and advocates aren’t giving up the push to legalize medical marijuana just yet, and they’re imploring leadership https://teapawt.net/t.co/OLy3cPOJzx
1
16
Massachusetts Bill Would Cap MDMA Therapy Costs at $5,000 The article Massachusetts Bill Would Cap MDMA Therapy Costs at $5,000 was originally published on Microdose. #psychedelics #PsychTwitter #psilocybin https://teapawt.net/t.co/crmpdFfx2k
28
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million Upon the closing which occurred on March 22, 2023, the purchase price was adjusted from $2.5 million and increased to approximately $3 million. https://teapawt.net/t.co/B7JRUjQM0v
3
Why Did Liontown Reject A $3.7-Billion Buyout Offer From Albemarle? Liontown Resources (ASX: LTR) said on Tuesday that it had rejected a non-binding indicative approach from top lithium producer Albemarle Corp (NYSE: #psychedelics #PsychTwitter https://teapawt.net/t.co/ZHQnUKIRqY
15